State of Wisconsin Investment Board
VRDN icon

State of Wisconsin Investment Board’s Viridian Therapeutics VRDN Stock Holding History

State of Wisconsin Investment Board’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Buy
70,244
+2,450
+4% +$72.8K ﹤0.01% 1548
2025
Q4 		$2.11M Buy
67,794
+10,889
+19% +$299K ﹤0.01% 1389
2025
Q3 		$1.23M Buy
56,905
+5,480
+11% +$98.8K ﹤0.01% 1531
2025
Q2 		$719K Buy
51,425
+7,036
+16% +$95.5K ﹤0.01% 1708
2025
Q1 		$598K Buy
44,389
+9,970
+29% +$170K ﹤0.01% 1681
2024
Q4 		$660K Buy
34,419
+9,197
+36% +$200K ﹤0.01% 1686
2024
Q3 		$574K Sell
25,222
-14,966
-37% -$245K ﹤0.01% 1802
2024
Q2 		$523K Buy
40,188
+17,918
+80% +$248K ﹤0.01% 1803
2024
Q1 		$390K Sell
22,270
-36,055
-62% -$699K ﹤0.01% 1874
2023
Q4 		$1.27M Sell
58,325
-14,729
-20% -$233K ﹤0.01% 1331
2023
Q3 		$1.12M Buy
73,054
+42,831
+142% +$817K ﹤0.01% 1368
2023
Q2 		$719K Sell
30,223
-1,302
-4% -$33.4K ﹤0.01% 1617
2023
Q1 		$802K Buy
31,525
+1,493
+5% +$47.9K ﹤0.01% 1582
2022
Q4 		$877K Buy
30,032
+11,714
+64% +$270K ﹤0.01% 1563
2022
Q3 		$376K Buy
+18,318
New +$329K ﹤0.01% 2114
2019
Q2 		– Sell
-2,360
Closed -$99K – 1603
2019
Q1 		$99K Buy
2,360
+540
+30% +$24.4K ﹤0.01% 1507
2018
Q4 		$83K Buy
1,820
+1,153
+173% +$66.7K ﹤0.01% 1506
2018
Q3 		$56K Hold
667
– – ﹤0.01% 1533
2018
Q2 		$64K Hold
667
– – ﹤0.01% 1464
2018
Q1 		$70K Hold
667
– – ﹤0.01% 1440
2017
Q4 		$104K Hold
667
– – ﹤0.01% 1424
2017
Q3 		$91K Hold
667
– – ﹤0.01% 1443
2017
Q2 		$129K Buy
+667
New +$113K ﹤0.01% 1430

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State of Wisconsin Investment Board's VRDN Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Viridian Therapeutics (VRDN) stake by 3.6% in Q1 2026, buying an estimated $72.8K and bringing the position to 70,244 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

State of Wisconsin Investment Board first reported a position in VRDN in Q2 2017 and has held it in 23 quarters since. The position peaked at $2.11M in Q4 2025. 225 funds tracked by Wall St. Rank hold VRDN as of Q1 2026.

  • State of Wisconsin Investment Board held 70,244 shares of Viridian Therapeutics worth $1.37M as of Q1 2026.
  • State of Wisconsin Investment Board bought 2,450 Viridian Therapeutics shares in Q1 2026, an estimated $72.8K.
  • Viridian Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1548 holding.
  • State of Wisconsin Investment Board first reported a position in Viridian Therapeutics in Q2 2017 and has held it in 23 quarters since.
  • State of Wisconsin Investment Board's Viridian Therapeutics position peaked at $2.11M in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.